XML 29 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2021     4,975,000 685,057,944          
Beginning balance at Dec. 31, 2021 $ 61,029   $ 0 $ 7 $ 34,112 $ 51,006   $ 374 $ (24,470)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) (2,930)         7,360   (10,290)  
Dividends—common stock (in shares) [1]       33,511          
Dividends—common stock [1] (950)     $ 0 4 (954)      
Dividends—preferred stock (228)         (228)      
Purchases of treasury stock (4,948)               (4,948)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       4,909,173          
Issuances of common stock and restricted stock, net of forfeitures 276     $ 0 276        
Exercises of stock options (in shares)       333,794          
Exercises of stock options 19     $ 0 19        
Compensation expense for restricted stock units 314       314        
Ending balance (in shares) at Dec. 31, 2022     4,975,000 690,334,422          
Ending balance at Dec. 31, 2022 52,582 $ 37 [2],[3] $ 0 $ 7 34,725 57,184 $ 37 [2],[3] (9,916) (29,418)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 6,535         4,887   1,648  
Dividends—common stock (in shares) [1]       39,420          
Dividends—common stock [1] (931)     $ 0 4 (935)      
Dividends—preferred stock (228)         (228)      
Purchases of treasury stock (718)               (718)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       5,731,927          
Issuances of common stock and restricted stock, net of forfeitures 299     $ 0 299        
Exercises of stock options (in shares)       136,899          
Exercises of stock options 10     $ 0 10        
Compensation expense for restricted stock units 503       503        
Ending balance (in shares) at Dec. 31, 2023     4,975,000 696,242,668          
Ending balance at Dec. 31, 2023 58,089 $ (25) [4] $ 0 $ 7 35,541 60,945 $ (25) [4] (8,268) (30,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 3,732         4,750   (1,018)  
Dividends—common stock (in shares) [1]       38,319          
Dividends—common stock [1] (932)     $ 0 5 (937)      
Dividends—preferred stock (228)         (228)      
Purchases of treasury stock (734)               (734)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       5,767,946          
Issuances of common stock and restricted stock, net of forfeitures 323     $ 0 323        
Exercises of stock options (in shares)       175,741          
Exercises of stock options 4     $ 0 4        
Compensation expense for restricted stock units 555       555        
Ending balance (in shares) at Dec. 31, 2024     4,975,000 702,224,674          
Ending balance at Dec. 31, 2024 $ 60,784   $ 0 $ 7 $ 36,428 $ 64,505   $ (9,286) $ (30,870)
[1] We declared dividends per share on our common stock of $0.60 in each quarter of 2024, 2023 and 2022.
[2] Impact from the adoption of ASU 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings (“TDR”) and Vintage Disclosures as of January 1, 2023.
[3] We have equity method investments in certain non-public entities which adopted ASU 2019-10, Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) as of January 1, 2023. The impact to retained earnings was recorded in the second quarter of 2023, on a one quarter lag consistent with our standard operating procedures for equity method investments.
[4] Impact from the adoption of ASU 2023-02, Investments - Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method as of January 1, 2024.